In stock · depth page
GHRH + GHRP combination context (RUO)
GHRH-receptor analogue and GHSR secretagogue · separate vials
CJC-1295 with DAC 10 mg and ipamorelin 10 mg · separate lines
For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide.
Orthogonal receptor tools under one project code are not proof of a validated co-formulation. There is no GHRH/GHRP blend SKU on this catalog.
Keep the lines separate
A GHRH-analogue line is CJC-1295 with DAC (CAS 446262-90-4). A GH secretagogue line is ipamorelin (CAS 170851-70-4). List each analogue on its own purchase-order line. The usual laboratory reason for naming both is two receptor classes under one project code.
No peer-reviewed primary papers that specifically study CJC-1295 with DAC plus ipamorelin co-administration are listed. The citations below are single-agent anchors.
Do not write “GHRH/GHRP blend” unless Sales confirms that phrase as an actual catalog SKU. It is not one on this page.
Identity
Form
Lyophilized powders, separate sealed vials
Strength
CJC-1295 with DAC 10 mg and ipamorelin 10 mg, as separate vials
Purity
≥99% HPLC (see each lot COA)
CAS
- CJC-1295 with DAC: 446262-90-4
- Ipamorelin: 170851-70-4
PubMed
Selected literature
- PMID 16352683 (2006) Teichman et al., Journal of Clinical Endocrinology & Metabolism — prolonged GH / IGF-I stimulation by CJC-1295
- PMID 17018654 (2006) Ionescu & Frohman, Journal of Clinical Endocrinology & Metabolism — GH pulsatility under continuous CJC-1295 stimulation
- PMID 9849822 (1998) Raun et al., European Journal of Endocrinology — ipamorelin, the first selective growth hormone secretagogue
Recent literature (2023–2026): No peer-reviewed primary papers that specifically study CJC-1295 with DAC plus ipamorelin co-administration are listed. The citations below are single-agent anchors.
Literature is scientific context only. A paper does not make a research vial into a licensed medicine.
Bench reconstitution
Reconstitute each lyophilized cake on its own compound brief, in bacteriostatic water, to the concentration the protocol specifies. Do not treat the two vials as one cake.
Diluent page: bacteriostatic water.
Storage
Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.
Certificate of analysis
Request a separate lot-matched COA for each analogue from request@pharmapeptidesrx.com.
Lab FAQ
Does this page claim a synergistic vial?
No. It is combination context for a dual-line research request. Name each compound, strength, quantity, and ship-to when you write request@pharmapeptidesrx.com. This page does not publish prices or banking details. Invoices go out from request@ only.
In this library
In stock · list price
Request from the catalog
Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.